1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Ac220: new trials by email Literature Review of Ac220 trials Research Report on Ac220
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD Quizartinib, Omacetaxine Mepesuccinate Injection - AML, FLT3-ITD Mutation | Phase 2 | Unknown | The University of Hong Kong | 40 | 2017-10-01 | 2020-12-10 |
The University of Hong Kong (1)
Hong Kong (1)